Shirui Wang

Synthesis and biological evaluation of a novel c-Myc inhibitor against colorectal cancer via blocking c-Myc/Max heterodimerization and disturbing its DNA binding.

Rui Li, Dan Luo, Hongjia Zhang, 2022, European journal of medicinal chemistry.

Current strategies for improving limitations of proteolysis targeting chimeras

Rui Li, Zhonghui Feng, Hongjia Zhang, 2022, Chinese Chemical Letters.

Discovery of the GSH responsive "Y-PROTACs" targeting ALK and CDK4/6 as a potential treatment for cancer.

Rui Li, Hongjia Zhang, Yuanyuan Liu, 2023, European journal of medicinal chemistry.

Synthesis and biological evaluation of a tumor-selective degrader of PARP1.

Rui Li, Hongjia Zhang, Rui-Cheng Deng, 2022, Bioorganic & medicinal chemistry.

Development of PROTAC degrader probe of CDK4/6 based on DCAF16.

Rui Li, Hongjia Zhang, Qingjia Xu, 2023, Bioorganic chemistry.

Development of PROTAC degrader probe of CDK4/6 based on DCAF16.

Rui Li, Hongjia Zhang, Qingjia Xu, 2023, Bioorganic chemistry.

Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer.

Bingyang Chu, Zhanzhan Feng, Su Yu, 2024, European journal of medicinal chemistry.

A Prognostic Model of Angiogenesis and Neutrophil Extracellular Traps Related Genes Manipulating Tumor Microenvironment in Colon Cancer

Yueming Sun, Dongsheng Zhang, Shirui Wang, 2023, Journal of Cancer.